TRAIL has been shown to induce apoptosis in ER-negative, but not in ER-positive cell lines (Rahman et al, 2009), perhaps explaining our observed reduced risk of ER-negative, but not of ER-positive, breast cancer in women with SLE. This evidence concerns the gene TNFSF10 and breast cancer.